Showing results (1251-1260 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|April 9, 2010
Effectiveness of milnacipran for the treatment of chronic pain in the orofacial regionMikiko Ito, Hiroyuki Kimura, Keizo Yoshida, et al.Clinical Neuropharmacology|April 9, 2010
Oxcarbazepine for the treatment of trichotillomaniaPaolo Leombruni, Filippo GastaldiClinical Neuropharmacology|May 27, 2010
Lamotrigine administration in panic disorder with agoraphobiaVasilios G Masdrakis, George N Papadimitriou, Panagiotis OulisClinical Neuropharmacology|May 27, 2010
Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importanceAsuman Orhan Varoglu, Abdulkadir Yildirim, Recep Aygul, et al.Clinical Neuropharmacology|June 2, 2009
Efficacy and tolerability of aripiprazole in first-episode drug-naive patients with schizophrenia: an open-label trialHitoshi Takahashi, Takashi Oshimo, Jun IshigookaClinical Neuropharmacology|June 2, 2009
Temporal lobe epilepsy confused with panic disorder: implications for treatmentStephen I Deutsch, Richard B Rosse, Indu M Sud, et al.Clinical Neuropharmacology|June 2, 2009
Oxcarbazepine treatment of restless legs syndrome: three case reportsLuis Jimenez-TrevinoClinical Neuropharmacology|December 1, 1990
Acute dystonic reaction in normal humans caused by catecholamine depletionU D McCann, D M Penetar, G BelenkyClinical Neuropharmacology|June 19, 2009
Single dose of fluoxetine increases muscle activation in chronic stroke patientsHanneke Irene Berends, Juliette Nijlant, Michel van Putten, et al.Clinical Neuropharmacology|August 1, 2009
Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trialIris Cohen-Yavin, Roni Yoran-Hegesh, Rael D Strous, et al.Pageof 236